Cti Biopharma Corp

CTICDelisted Jun 26, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0000891293

SEC filings (opens in a new tab)

Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Cti Biopharma Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of CTIC: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Q3 2021	Change
Holders	50	56	+6
Shares	53.2M	54.1M	+871.2K (+1.6%)
Value	$133.1M	$159.6M	+$26.5M (+19.9%)

New holders (13)

Institutions that held Cti Biopharma Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CTIC in Q3 2021
Institution	Shares	Value	% of portfolio
Kennedy Capital Management, Inc.	504,382	$1.49M	0.03%
Susquehanna International Group, LLP	336,793	$994.0K	0.00%
Gyon Technologies Capital Management, LP	135,003	$398.0K	0.11%
EPIQ Capital Group, LLC	120,939	$357.0K	0.04%
Advisory Alpha, LLC	103,717	$306.0K	0.02%
Raymond James Financial Services Advisors, Inc.	72,871	$215.0K	0.00%
Citadel Advisors LLC	69,673	$205.0K	0.00%
Capstone Investment Advisors, LLC	50,445	$149.0K	0.00%
Group One Trading, L.P.	38,495	$114.0K	0.00%
Qube Research & Technologies Ltd	24,688	$73.0K	0.00%
Wolverine Trading, LLC	23,253	$68.0K	0.00%
Jane Street Group, LLC	17,319	$51.0K	0.00%
Tower Research Capital LLC (TRC)	3,230	$10.0K	0.00%

Sold out (7)

Institutions that held Cti Biopharma Corp at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of CTIC in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Squarepoint Ops LLC	72,325	$181.0K
Occudo Quantitative Strategies LP	55,555	$139.0K
Goldman Sachs Group Inc	41,558	$104.0K
Quantitative Systematic Strategies LLC	25,686	$64.0K
Citigroup Inc	3	$0
Ancora Advisors, LLC	1	$0
Sound Income Strategies, LLC	33	$0